Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion

Diana Malarikova, Radek Jorda, Kristyna Kupcova, Jana Senavova, Alexandra Dolnikova, Eva Pokorna, Dmitry Kazantsev, Kristina Nozickova, Dana Sovilj, Celine Bellanger, David Chiron, Ladislav Andera, Vladimir Krystof, Miroslav Strnad, Karel Helman, Magdalena Klanova, Marek Trneny, Ondrej Havranek, Pavel Klener

Open source

DOI: 10.1186/s40164-024-00499-2
Published: 2024-03-25
Container: Experimental Hematology & Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40164-024-00499-2,
  title = {Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion},
  author = {Diana Malarikova and Radek Jorda and Kristyna Kupcova and Jana Senavova and Alexandra Dolnikova and Eva Pokorna and Dmitry Kazantsev and Kristina Nozickova and Dana Sovilj and Celine Bellanger and David Chiron and Ladislav Andera and Vladimir Krystof and Miroslav Strnad and Karel Helman and Magdalena Klanova and Marek Trneny and Ondrej Havranek and Pavel Klener},
  year = {2024},
  journal = {Experimental Hematology \&amp; Oncology},
  doi = {10.1186/s40164-024-00499-2},
  url = {https://doi.org/10.1186/s40164-024-00499-2}
}

RIS

TY  - JOUR
TI  - Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion
AU  - Diana Malarikova
AU  - Radek Jorda
AU  - Kristyna Kupcova
AU  - Jana Senavova
AU  - Alexandra Dolnikova
AU  - Eva Pokorna
AU  - Dmitry Kazantsev
AU  - Kristina Nozickova
AU  - Dana Sovilj
AU  - Celine Bellanger
AU  - David Chiron
AU  - Ladislav Andera
AU  - Vladimir Krystof
AU  - Miroslav Strnad
AU  - Karel Helman
AU  - Magdalena Klanova
AU  - Marek Trneny
AU  - Ondrej Havranek
AU  - Pavel Klener
PY  - 2024
JO  - Experimental Hematology &amp; Oncology
DO  - 10.1186/s40164-024-00499-2
UR  - https://doi.org/10.1186/s40164-024-00499-2
ER  -

APA

Malarikova, D., Jorda, R., Kupcova, K., Senavova, J., Dolnikova, A., Pokorna, E., Kazantsev, D., Nozickova, K., Sovilj, D., Bellanger, C., Chiron, D., Andera, L., Krystof, V., Strnad, M., Helman, K., Klanova, M., Trneny, M., Havranek, O., & Klener, P. (2024). Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion. Experimental Hematology & Oncology. https://doi.org/10.1186/s40164-024-00499-2

Source records

crossref · retrieved 2026-09-25T03:53:49.914Z